BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30415456)

  • 1. Imaging tryptophan uptake with positron emission tomography in glioblastoma patients treated with indoximod.
    Lukas RV; Juhász C; Wainwright DA; James CD; Kennedy E; Stupp R; Lesniak MS
    J Neurooncol; 2019 Jan; 141(1):111-120. PubMed ID: 30415456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tryptophan PET Imaging of the Kynurenine Pathway in Patient-Derived Xenograft Models of Glioblastoma.
    Guastella AR; Michelhaugh SK; Klinger NV; Kupsky WJ; Polin LA; Muzik O; Juhász C; Mittal S
    Mol Imaging; 2016; 15():. PubMed ID: 27151136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI.
    Bosnyák E; Kamson DO; Robinette NL; Barger GR; Mittal S; Juhász C
    J Neurooncol; 2016 Jan; 126(2):317-25. PubMed ID: 26514361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-tumor cell IDO1 predominantly contributes to enzyme activity and response to CTLA-4/PD-L1 inhibition in mouse glioblastoma.
    Zhai L; Ladomersky E; Dostal CR; Lauing KL; Swoap K; Billingham LK; Gritsina G; Wu M; McCusker RH; Binder DC; Wainwright DA
    Brain Behav Immun; 2017 May; 62():24-29. PubMed ID: 28179106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging correlates of differential expression of indoleamine 2,3-dioxygenase in human brain tumors.
    Batista CE; Juhász C; Muzik O; Kupsky WJ; Barger G; Chugani HT; Mittal S; Sood S; Chakraborty PK; Chugani DC
    Mol Imaging Biol; 2009; 11(6):460-6. PubMed ID: 19434461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib.
    Riess C; Schneider B; Kehnscherper H; Gesche J; Irmscher N; Shokraie F; Classen CF; Wirthgen E; Domanska G; Zimpfer A; Strüder D; Junghanss C; Maletzki C
    Front Immunol; 2020; 11():55. PubMed ID: 32117235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of L- and D-5-[
    Tang T; Gill HS; Ogasawara A; Tinianow JN; Vanderbilt AN; Williams SP; Hatzivassiliou G; White S; Sandoval W; DeMent K; Wong M; Marik J
    Nucl Med Biol; 2017 Aug; 51():10-17. PubMed ID: 28511073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 5-[
    Giglio BC; Fei H; Wang M; Wang H; He L; Feng H; Wu Z; Lu H; Li Z
    Theranostics; 2017; 7(6):1524-1530. PubMed ID: 28529635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2,3-dioxygenase 1.
    Zitron IM; Kamson DO; Kiousis S; Juhász C; Mittal S
    Cancer Biol Ther; 2013 Apr; 14(4):333-9. PubMed ID: 23358471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological stress-induced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans.
    Kiank C; Zeden JP; Drude S; Domanska G; Fusch G; Otten W; Schuett C
    PLoS One; 2010 Jul; 5(7):e11825. PubMed ID: 20689575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of tryptophan metabolism in the nontumoral hemisphere in patients with malignant glioma.
    Kamson DO; Lee TJ; Varadarajan K; Robinette NL; Muzik O; Chakraborty PK; Snyder M; Barger GR; Mittal S; Juhász C
    J Nucl Med; 2014 Oct; 55(10):1605-10. PubMed ID: 25189339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy.
    Zhai L; Dey M; Lauing KL; Gritsina G; Kaur R; Lukas RV; Nicholas MK; Rademaker AW; Dostal CR; McCusker RH; Raizer JJ; Parsa AT; Bloch O; Wainwright DA
    J Clin Neurosci; 2015 Dec; 22(12):1964-8. PubMed ID: 26279502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
    Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
    J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of glioblastomas from metastatic brain tumors by tryptophan uptake and kinetic analysis: a positron emission tomographic study with magnetic resonance imaging comparison.
    Kamson DO; Mittal S; Buth A; Muzik O; Kupsky WJ; Robinette NL; Barger GR; Juhász C
    Mol Imaging; 2013; 12(5):327-37. PubMed ID: 23759373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential kinetics of α-[¹¹C]methyl-L-tryptophan on PET in low-grade brain tumors.
    Juhász C; Muzik O; Chugani DC; Chugani HT; Sood S; Chakraborty PK; Barger GR; Mittal S
    J Neurooncol; 2011 May; 102(3):409-15. PubMed ID: 20676727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival.
    John F; Bosnyák E; Robinette NL; Amit-Yousif AJ; Barger GR; Shah KD; Michelhaugh SK; Klinger NV; Mittal S; Juhász C
    Neuro Oncol; 2019 Feb; 21(2):264-273. PubMed ID: 30346623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal Imaging of Nonenhancing Glioblastoma Regions.
    John F; Robinette NL; Amit-Yousif AJ; Bosnyák E; Barger GR; Shah KD; Mittal S; Juhász C
    Mol Imaging; 2019; 18():1536012119885222. PubMed ID: 31736437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo uptake and metabolism of alpha-[11C]methyl-L-tryptophan in human brain tumors.
    Juhász C; Chugani DC; Muzik O; Wu D; Sloan AE; Barger G; Watson C; Shah AK; Sood S; Ergun EL; Mangner TJ; Chakraborty PK; Kupsky WJ; Chugani HT
    J Cereb Blood Flow Metab; 2006 Mar; 26(3):345-57. PubMed ID: 16079785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas.
    Bosnyák E; Kamson DO; Guastella AR; Varadarajan K; Robinette NL; Kupsky WJ; Muzik O; Michelhaugh SK; Mittal S; Juhász C
    Neuro Oncol; 2015 Sep; 17(9):1284-92. PubMed ID: 26092774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunosuppressive role of indoleamine 2, 3-dioxygenase in glioblastoma: mechanism of action and immunotherapeutic strategies.
    Hosseinalizadeh H; Mahmoodpour M; Samadani AA; Roudkenar MH
    Med Oncol; 2022 Jun; 39(9):130. PubMed ID: 35716323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.